Table 1.
Pathologic response and type of surgery per treatment group
| Treatment group | Paclitaxel and FAC/FEC (n = 26) | Eribulin and FAC/FEC (n = 21) |
|---|---|---|
| Residual cancer burden category a | ||
| 0 (pCR) | 7 (27) | 1 (5) |
| I | 7 (27) | 0 (0) |
| II | 8 (31) | 8 (38) |
| III | 4 (15) | 12 (57) |
| Type of surgery | ||
| Mastectomy | 17 (65) | 16 (76) |
| Breast conserving surgery | 9 (35) | 5 (24) |
a
Residual cancer burden (RCB) was calculated by the RCB calculator (by pathologists: http://www3.mdanderson.org/app/medcalc/index.cfm?pagename=jsconvert3).
Abbreviations: FAC/FEC, 5‐fluorouracil, either doxorubicin or epirubicin, and cyclophosphamide; pCR, pathologic complete response.